Cargando…
Vitexin alleviates lipopolysaccharide-induced islet cell injury by inhibiting HMGB1 release
Diabetes mellitus (DM) is a chronic metabolic disease, where the predominant pathogenesis is pancreatic β-cells dysfunction or injury. It has been well established that inflammation leads to a gradual exhaustion of pancreatic β-cell function with decreased β-cell mass likely resulting from pancreati...
Autores principales: | Wang, Feifei, Yin, Jiajing, Ma, Yujin, Jiang, Hongwei, Li, Yanbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367348/ https://www.ncbi.nlm.nih.gov/pubmed/28098903 http://dx.doi.org/10.3892/mmr.2017.6114 |
Ejemplares similares
-
Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway
por: Lu, Ying, et al.
Publicado: (2018) -
Release of HMGB1 in Podocytes Exacerbates Lipopolysaccharide-Induced Acute Kidney Injury
por: Gao, Zhao, et al.
Publicado: (2021) -
Effects of propofol on lipopolysaccharide-induced expression and release
of HMGB1 in macrophages
por: Wang, T., et al.
Publicado: (2015) -
Validation and application by HPLC for simultaneous determination of vitexin-2″-O-glucoside, vitexin-2″-O-rhamnoside, rutin, vitexin, and hyperoside
por: Wang, Chang-He, et al.
Publicado: (2011) -
Three Ingredients of Safflower Alleviate Acute Lung Injury and Inhibit NET Release Induced by Lipopolysaccharide
por: Wang, Yun-peng, et al.
Publicado: (2020)